Health Library
February 11, 2026
Question on this topic? Get an instant answer from August.
Niba warategetswe Zepbound kandi ubwishingizi bwawe buri kuri Aetna, ikibazo cyawe cya mbere ni ngombwa ku bijyanye no kwishyuza. Ni ikibazo cyiza kandi gikomeye. Imiti nk'iyi ishobora kugera hejuru ya 1.000 by'amadolari ku kwezi udashyigikiwe, bityo kumenya aho ugeze gutera inkunga byihindura cyane.
Iki ni cyo gisubizo gito: imishinga isanzwe ya Aetna igenewe abakoresha yarahagaritse kwishyura Zepbound kugira ngo ikoreshwe mu igenzura ry'umubyibuho ukabije kuva kuwa 1 Nyakanga 2025. Ariko ntibivuze ko ibyago byose byugarijwe. Imishinga imwe ya Aetna iracyayishyura, impamvu zidasanzwe zishobora gusabwa, kandi hari amahirwe yo kubona igabanuka ry'ibiciro bishobora kugabanya igiciro mu buryo bugaragara. Twihanganiye byose.
Kugeza hagati ya 2025, imishinga myinshi ya Aetna yishyuraga Zepbound kugira ngo igenzure umubyibuho ukabije mu gihe gikomeye. Ibyo byarahindutse ubwo CVS Caremark, ishinzwe gucunga inyungu z'imiti ya Aetna, yavuze ko Zepbound itari mu murongo wayo usanzwe. Umurongo ni urutonde rw'imiti ubwishingizi bwawe bwemera kwishyura.
CVS Caremark yagiranye amasezerano yo kugabanya ibiciro na rwiyemezamiro wa Wegovy, undi muti wa GLP-1, kandi ikora Wegovy nk'ikihari cyatoranijwe. Iki gihinduka cyagize ingaruka ku mishanga yombi ya Aetna Standard Plan na Advanced Control Plan.
Nuko niba uri kuri umwe muri iyi mishanga isanzwe kandi ugahingutse kwa muganga ugahabwa Zepbound uyu munsi, bishobora kuzagaruka ko itishyuzwa. Ibikoresho byanditswe birimo Wegovy, Saxenda, Qsymia, na orlistat.
Iki cyaha kitezweho kuguma mu gihe gikomeye kugeza muri 2026 kubw'imishinga isanzwe y'abakoresha.
Yego, imwe iracyayishyuza. Kwishyura bitewe n'ubwoko bw'umushinga wa Aetna ufite. Ntabwo imishinga yose ikurikiza umushinga umwe.
Imishinga y'abakoresha yishyura ubwayo. Abakoresha benshi bakomeye bashinzwe kwitaho ubwishingizi bwabo binyuze kuri Aetna ariko bagafata ibyemezo by'uko imiti yishyurwa. Niba umukoresha wawe afite umushinga wishyura ubwayo, ashobora guhitamo kugumana Zepbound mu murongo, n'ubwo imishinga isanzwe ya Aetna yayikuyemo. Birakwiye kwegera ishami rya HR ryawe ngo wemeze niba umushinga wihariye w'ikigo cyawe ukihariye imiti ya GLP-1 yo kugenzura umubyibuho.
Imishinga yishyuza Zepbound kubw'uburwayi bwo gusinzira (OSA). Zepbound yabonye uburenganzira bwo kwemerwa na FDA kubw'uburwayi bwo gusinzira bukabije bwo gusinzira mu mpera za 2024. Imishinga imwe ya Aetna ishobora kugumya kwishyura iyo itegekwa kugira ngo ikoreshwe cyane kubw'OSA aho guhitamo guhabwa amavuta. Ariko, n'ubu nzira yaragoye, kuko imishinga imwe yavuze ko Zepbound itari mu cyiciro cy'ubwo bwoko bwose.
Imishinga ya Aetna Medicare Advantage. Amategeko ya Medicare adasanzwe ntashyigikira imiti yo kugabanya ibiro. Ariko, Medicare ishobora kwishyura Zepbound iyo yategetswe kubw'uburwayi bwo gusinzira. Inyungukiramubare mushya y'igihugu kitwa BALANCE, yatangajwe mu Kuboza 2025, ishobora kongera kugera kuri Medicare na Medicaid GLP-1 kuva hagati ya 2026. Imishinga ya Part D ishobora kwisanga muri Mutarama 2027.
Kubw'imishinga ya Aetna ikishyura Zepbound, uburenganzira bwa mbere busabwa buri gihe. Bivuze ko umuganga wawe agomba gutanga impapuro kuri Aetna byemeza ko imiti ari ngombwa mbere yuko pharmacy iyihabwa.
Dore ibyo Aetna akunda kureba mu gihe cyo gusaba uburenganzira bwa mbere:
Ibyemezo by'uburenganzira bwa mbere bikunda kugaruka mu gihe cy'iminsi 1-2. Nimba byemewe, uzakomeza kwishyura igihembo cyawe cyangwa ubwishingizi nyuma yo kurangiza kwishyura ibishoboka byose.
Abo 50% by'abashobora bose bakenera ubwoko bumwe bw'uburenganzira bwa mbere, kandi hafi kimwe cya kane cyibaza ko bagomba kugerageza undi muti mbere.
Kwangira ntibivuze ko ari ihurizo. Ufite uburenganzira bwo kurwanira, kandi ibyiza bishobora kuba byiza kuruta uko wabitekereza.
Ubushakashatsi bugaragaza ko 80% by'uburenganzira bwa mbere bwanze kwishyuza bahindurwa igihe ubuvugizi bufitanye ibitabo bifatika. Ariko abagera kuri 10% by'abashobora bagerageza kwirengagiza. Iki gice cyihagarariro abantu benshi bashobora kuba baragize uburenganzira ariko bakumva ko byarangiye.
Dore uko inzira yo gusaba ubutabazi ikora:
Imishinga ya Aetna yo gusaba uburenganzira bwa mbere n'inyungukiramubare yo gusaba ishobora gutangwa n'umuganga wawe binyuze muri fax cyangwa sisitemu za elegitoroniki. Abafatanije n'ubwishingizi basabwa gusubiza ibyifuzo bidasubirwaho mu gihe cya amasaha 72 mu rwego rw'amategeko.
Kumenya uko igiciro giteye bishobora kugufasha guteganya, uko kwishyura kwanyu kwaba kumeze kose.
Hamwe no kwishyura kwa Aetna n'ikarita yo kubika. Niba umushinga wawe ushyigikira Zepbound, Ikarita yo kubika ya Zepbound yo muri Eli Lilly ishobora kugabanya igiciro cyawe kugeza ku 25 by'amadolari ku kwezi. Ikarita yo kubika yo muri 2026 yishyura kugeza kuri 100 by'amadolari ku gice cy'ukwezi, hamwe n'ikiguzi cy'umwaka cy'1.300 by'amadolari. Iyi karita irishyurwa kubuntu kugira ngo ikoreshwe kandi irahari kubantu bose bafite ubwishingizi bwo mu rwego rw'abakoresha.
Hamwe na Aetna ariko ntaho kwishyura Zepbound. Niba ufite ubwishingizi bwa Aetna butishyuzu Zepbound, ikarita yo kubika iracyagufasha. Muri iki gihe, ushobora kuba ufite uburenganzira bwo kwishyuza kugeza ku 499 by'amadolari ku kwezi kubw'ipen yo gukoresha rimwe. Ikarita yishyura kugeza kuri 620 by'amadolari ku kwezi mu kugabanya, hamwe n'ikiguzi cy'umwaka cy'8.060.
Udashingiwe n'ubwishingizi. Igiciro cya Zepbound kigera kuri 1.086 by'amadolari ku kwezi. Udashingiwe n'ubwishingizi, uburyo bwiza bwo kwishyura burimo ni LillyDirect, itanga Zepbound amavide yo gukoresha rimwe guhera ku 299 kugeza kuri 449 by'amadolari ku kwezi bitewe n'uburyo bukenewe.
Abantu bafite ubwishingizi bwa leta (Medicare, Medicaid, TRICARE, cyangwa VA) ntibafite uburenganzira bwo gukoresha ikarita yo kubika.
Niba Zepbound itari mu murongo wawe, Aetna ikoresha imiti myinshi ivuguruye yo kugenzura umubyibuho:
Buri kimwe muri ibi gifite ibyo bisaba byo kwishyura kare n'uburyo bwo kugabanya igiciro. Umuganga wawe ashobora kugufasha kumenya icyiza cyane kishingiye ku mateka yawe y'ubuzima n'intego zawe.
Kuko kwishyura bihinduka ku mushinga ku mushinga, gusuzuma ibyiza byawe ni intambwe ikomeye. Dore uburyo bubiri bwo kubikora:
Injira kuri portali y'abanyamuryango ba Aetna. Jya ku ishami ry'imiti cyangwa ry'ibiyobyabwenge kandi ukoreshe uburyo bwo kureba imiti kugira ngo usuzume Zepbound. Hitamo umwaka wawe wa gahunda kandi bizagaragaza niba imiti yishyuzwa, iryo rwego ibarirwamo, kandi niba uburenganzira bwa mbere busabwa.
Wandikire Aetna ahantu hose. Fata ikarita yawe y'ubwishingizi n'umubare wa politiki. Wambaze umuhagarariye byihariye niba Zepbound iri ku murongo wawe kandi ibyo bisabwa by'uburenganzira bwa mbere.
Wegera ishami rya HR ry'umukoresha wawe. Niba ufite umushinga wishyura ubwayo, HR ishobora gusobanura niba ikigo cyawe cyahisemo kwishyura imiti yo kugabanya ibiro mu gihembo cy'ibyiza byo gukoresha.
Ejo Aetna yishyura Zepbound? Kubw'imishinga myinshi y'abakoresha, kuri ubu ntabwo. Ibyo byarahindutse mu Nyakanga 2025 ubwo CVS Caremark yagendaga kuri Wegovy nk'ikihari cyihariye cya GLP-1. Ariko, imishinga y'abakoresha yishyura ubwayo, ibisaba byihariye bya OSA, n'inyungukiramubare by'umurongo byemewe bishobora kugumya gufungura umuryango wo kwishyura.
Niba waranzwe, gusaba ubutabazi ufite ibitabo bifatika birakwiye kwitabwaho. Kandi niba kwishyura koko bitaraboneka binyuze mu mushinga wawe, Ikarita yo kubika ya Zepbound na LillyDirect bitanga uburyo bwo kugabanya igiciro.
Icy'ingenzi ni ukutavuga ko kwanga bivuga ko nta mahirwe ufite. Vugana n'umuganga wawe, soma ibisobanuro byawe byihariye, kandi urebe buri nzira iboneka. Kugera ku buvuzi bishobora, kandi hari inzira nyinshi zibigeraho kuruta uko abantu benshi babibona.
Inyuguti zidasubirwamo: Ibi bintu ni ibyo gutanga amakuru gusa kandi ntibyigana ubujyanama bw'inzobere mu bw'ubuvuzi cyangwa ubwishingizi. Uburenganzira bwo kwishyura buhinduka kenshi. Komeza kwemeza ibyiza byawe uhite na Aetna kandi wibaze umuganga ufite uburenganzira kugira ngo utange ibyemezo byo kwivuza.
6Mpeople
Get clear medical guidance
on symptoms, medications, and lab reports.